Clinical Trials Browser

Interventional × Erythroplasia × Head & Neck × Clear all

Erythroplasia, Leukoplakia, Oral

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Head & Neck

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Phase NA Active not recruiting

338 enrolled

Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

NCT05536037 2025-05-15

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Phase 1 Terminated

4 enrolled

Head & Neck

Erythroplasia, Leukoplakia, Mouth Neoplasms

NCT05296941 2023-09-08

PMOD

Phase NA Recruiting

200 enrolled

Head & Neck

Erythroplasia, Leukoplakia, Mouth Neoplasms, Lichen Planus, Oral

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Head & Neck

Erythroplasia, Leukoplakia, Oral

NCT03990636 2019-06-19

PDTMALAC

Phase 2 Unknown

40 enrolled

Head & Neck

Actinic cheilitis, Erythroplasia, Leukoplakia

NCT00571974 2015-03-24

Treatment of Oral Premalignant Lesions With 5-ALA PDT

Phase 1/2 Completed

29 enrolled 6 charts

Head & Neck

Erythroplasia, Leukoplakia

Clinical Trials

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

PMOD

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

PDTMALAC

Treatment of Oral Premalignant Lesions With 5-ALA PDT